MBOT — Microbot Medical Cashflow Statement
0.000.00%
Last trade - 00:00- $146.75m
- $114.07m
- 37
- 21
- 54
- 29
Annual cashflow statement for Microbot Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -9.17 | -11.3 | -13.2 | -10.7 | -11.4 |
| Depreciation | |||||
| Non-Cash Items | 1.87 | 1.39 | 1.75 | 2.11 | 1.58 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.018 | 0.497 | -0.228 | -0.011 | 0.942 |
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -7.25 | -9.35 | -11.5 | -8.53 | -8.83 |
| Capital Expenditures | -0.091 | -0.069 | -0.084 | -0.033 | -0.025 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -2.68 | 3.27 | -3.75 | 2.01 | 1.56 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -2.77 | 3.2 | -3.84 | 1.97 | 1.54 |
| Financing Cash Flow Items | -3.38 | 0 | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | -3.38 | 0 | 4.32 | 6.56 | 7.94 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -13.4 | -6.15 | -11.1 | -0.002 | 0.646 |